<DOC>
	<DOCNO>NCT01004653</DOCNO>
	<brief_summary>A single center , Open-Label phase IV clinical trial conduct healthy elder ( equal 61 year evaluate immunogenicity safety Sinovac 's 15Î¼g H1N1 influenza A Vaccine ( Split virion ) , Inactivated .</brief_summary>
	<brief_title>A Clinical Trial Split-virion Influenza A/H1N1 Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy male female age 60 old 2 . Be able show legal identity card sake recruitment 3 . Volunteers able understand sign inform consent 1 . Cases , cure case close contact influenza A ( H1N1 ) virus 2 . Women pregnancy , lactation pregnant 60 day 3 . Subject medical history following : allergic history , allergic ingredient vaccine , egg , egg protein , etc 4 . Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain 5 . Autoimmune disease immunodeficiency 6 . Asthma unstable require emergent care , hospitalization intubation past two year require use oral intravenous corticosteroid 7 . Diabetes mellitus ( type I II ) , exception gestational diabetes 8 . History thyroidectomy thyroid disease require medication within past 12 month 9 . Serious angioedema episode within previous 3 year require medication previous two year 10 . Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draws 11 . Active malignancy treat malignancy reasonable assurance sustain cure malignancy likely recur period study 12 . Seizure disorder : Febrile seizure age two year old Seizures secondary alcohol withdrawal 3 year ago , A singular seizure require treatment within last 3 year 13 . Asplenia , functional asplenia condition result absence removal spleen 14 . GuillainBarre Syndrome 15 . Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) 16 . History blood product seasonal influenza vaccine administration within 3 month dose 17 . Administration investigational research agent within 30 day dose 18 . Administration live attenuate vaccine within 30 day dose 19 . Administration subunit inactivate vaccine , e.g. , pneumococcal vaccine , allergy treatment antigen injection , within 14 day dose 20 . Be receive antiTB prophylaxis therapy currently 21 . Axillary temperature &gt; 37.0 centigrade time dose 22 . Psychiatric condition precludes compliance protocol : Past present psychosis Past present bipolar disorder require therapy well control medication past two year Disorder require lithium Suicidal ideation occur within five year prior enrollment 23 . Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>